Implementing criteria-led discharge for acute admissions to facilitate the elective recovery from COVID-19: an example in acute tonsillitis.

decision support, clinical health policy healthcare quality improvement hospital medicine nurses

Journal

BMJ open quality
ISSN: 2399-6641
Titre abrégé: BMJ Open Qual
Pays: England
ID NLM: 101710381

Informations de publication

Date de publication:
03 2023
Historique:
received: 11 09 2022
accepted: 08 03 2023
medline: 31 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: ppublish

Résumé

Healthcare systems face unprecedented numbers of patients waiting for elective treatments in the wake of the COVID-19 pandemic. Hospitals must urgently optimise patient pathways and build capacity to meet the populations health needs. Criteria-led discharge (CLD) is frequently used to optimise elective care pathways but may hold potential in discharging patients at the end of an acute hospital admission. We conducted a quality improvement project to design and introduce a novel inpatient pathway using CLD for patients with severe acute tonsillitis. Our analysis compared the standardisation of treatment, length of stay, discharge time and readmission rate between those treated on the novel pathway compared with standard treatment. The study population included 137 patients admitted to a tertiary centre with acute tonsillitis. Introduction of the tonsillitis pathway using CLD resulted in a significant reduction in median length of stay from 24 hours to 18 hours. Of those treated on the tonsillitis pathway, 52.2% were discharged prior to midday compared with 29.1% who received standard treatment. No patient discharged using CLD required readmission. CLD is safe and effective at reducing length of stay in patients requiring acute hospital admission for acute tonsillitis. CLD should be used and evaluated in further novel patient pathways across different areas of medicine to optimise care and build capacity for provision of elective healthcare services. Further research is required to investigate safe and optimal criteria which indicate patients are fit for discharge.

Sections du résumé

BACKGROUND
Healthcare systems face unprecedented numbers of patients waiting for elective treatments in the wake of the COVID-19 pandemic. Hospitals must urgently optimise patient pathways and build capacity to meet the populations health needs. Criteria-led discharge (CLD) is frequently used to optimise elective care pathways but may hold potential in discharging patients at the end of an acute hospital admission.
METHODS
We conducted a quality improvement project to design and introduce a novel inpatient pathway using CLD for patients with severe acute tonsillitis. Our analysis compared the standardisation of treatment, length of stay, discharge time and readmission rate between those treated on the novel pathway compared with standard treatment.
RESULTS
The study population included 137 patients admitted to a tertiary centre with acute tonsillitis. Introduction of the tonsillitis pathway using CLD resulted in a significant reduction in median length of stay from 24 hours to 18 hours. Of those treated on the tonsillitis pathway, 52.2% were discharged prior to midday compared with 29.1% who received standard treatment. No patient discharged using CLD required readmission.
CONCLUSION
CLD is safe and effective at reducing length of stay in patients requiring acute hospital admission for acute tonsillitis. CLD should be used and evaluated in further novel patient pathways across different areas of medicine to optimise care and build capacity for provision of elective healthcare services. Further research is required to investigate safe and optimal criteria which indicate patients are fit for discharge.

Identifiants

pubmed: 36990649
pii: bmjoq-2022-002123
doi: 10.1136/bmjoq-2022-002123
pmc: PMC10069274
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Clin Otolaryngol. 2013 Oct;38(5):410-5
pubmed: 23910693
Br J Anaesth. 2018 Oct;121(4):730-738
pubmed: 30236235
BMJ Clin Evid. 2014 Jul 22;2014:
pubmed: 25051184
J Pediatr Nurs. 2018 Jul-Aug;41:60-68
pubmed: 29398316
Nurs Child Young People. 2012 Nov;24(9):21-3
pubmed: 23311262
Nurs Crit Care. 2003 Mar-Apr;8(2):56-61
pubmed: 12737189
J R Nav Med Serv. 2015;101(1):69-73
pubmed: 26292396
BMJ. 2022 Apr 19;377:o995
pubmed: 35440437
J Eval Clin Pract. 2012 Feb;18(1):19-24
pubmed: 21087365
Nurs Times. 2011 Oct 4-10;107(39):18-20
pubmed: 22046672
J Nurs Care Qual. 2019 Apr/Jun;34(2):121-126
pubmed: 30198948

Auteurs

Callum Findlay (C)

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK c.findlay@soton.ac.uk.
Department of Otolaryngology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Wei Chern Gavin Fong (WCG)

Department of Otolaryngology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Simon Goldie (S)

Department of Otolaryngology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Huw Jones (H)

Department of Otolaryngology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH